Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK163090 in severe major depressive disorder
NCT00896363Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2009
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GSK163090 in major depressive disorder (MDD), sponsored by GSK. Started Apr 2009; status: completed.
02
Drugs
GSK163090
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00896363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00896363.